Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ma

Showing results (1401-1410 of 1,592) with videos related to

Pageof 160
Sort By:
Nature|May 20, 2026
Mitochondrial L-2-hydroxyglutarate is a physiological signalling metaboliteRam P Chakrabarty, Jonathan G Van Vranken, Yuki Aoi, et al.
Nature|February 17, 2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingA A Alizadeh, M B Eisen, R E Davis, et al.
MMWR. Morbidity and Mortality Weekly Report|June 15, 2023
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023Kevin C Ma, Philip Shirk, Anastasia S Lambrou, et al.
Nature|June 4, 2025
Integrated photonic source of Gottesman-Kitaev-Preskill qubitsM V Larsen, J E Bourassa, S Kocsis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010 - 2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
Cancer Discovery|April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET InhibitorsFederica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
The New England Journal of Medicine|February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Journal of the National Cancer Institute|April 5, 2017
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLCImane Chaib, Niki Karachaliou, Sara Pilotto, et al.
The Journal of Infectious Diseases|May 6, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010-2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2023
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trialK Jhaveri, L D Eli, H Wildiers, et al.
Pageof 160

Showing results (1401-1410 of 1,592) with videos related to

Sort By:
Pageof 160
Nature|May 20, 2026
Mitochondrial L-2-hydroxyglutarate is a physiological signalling metaboliteRam P Chakrabarty, Jonathan G Van Vranken, Yuki Aoi, et al.
Nature|February 17, 2000
Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingA A Alizadeh, M B Eisen, R E Davis, et al.
MMWR. Morbidity and Mortality Weekly Report|June 15, 2023
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023Kevin C Ma, Philip Shirk, Anastasia S Lambrou, et al.
Nature|June 4, 2025
Integrated photonic source of Gottesman-Kitaev-Preskill qubitsM V Larsen, J E Bourassa, S Kocsis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010 - 2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
Cancer Discovery|April 2, 2024
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET InhibitorsFederica Pecci, Seshiru Nakazawa, Biagio Ricciuti, et al.
The New England Journal of Medicine|February 22, 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and ChildrenAlexander Drilon, Theodore W Laetsch, Shivaani Kummar, et al.
Journal of the National Cancer Institute|April 5, 2017
Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLCImane Chaib, Niki Karachaliou, Sara Pilotto, et al.
The Journal of Infectious Diseases|May 6, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010-2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2023
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trialK Jhaveri, L D Eli, H Wildiers, et al.
Pageof 160